Kevin D. Bunker - Feb 1, 2023 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Signature
By: /s/ Melissa B. Epperly, Attorney-in-Fact for Kevin D. Bunker
Stock symbol
ZNTL
Transactions as of
Feb 1, 2023
Transactions value $
$0
Form type
4
Date filed
2/1/2023, 06:09 PM
Previous filing
Oct 3, 2022
Next filing
Feb 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZNTL Common Stock Gift $0 -30K -3.69% $0.00 784K Nov 9, 2022 Direct
transaction ZNTL Common Stock Award $0 +91.4K +11.65% $0.00 875K Feb 1, 2023 Direct F1
holding ZNTL Common Stock 350 Feb 1, 2023 As UTMA custodian for sons
holding ZNTL Common Stock 95K Feb 1, 2023 See Footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZNTL Stock Option (Right to Buy) Award $0 +133K $0.00 133K Feb 1, 2023 Common Stock 133K $23.65 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date.
F2 Represents shares nominally held by Sundog Ranch, Inc. on behalf of the Bunker Family Protection Trust, the sole shareholder of Sundog Ranch, Inc. The Reporting Person and his wife are the primary beneficiaries of the Bunker Family Protection Trust and the Reporting Person and his wife are also directors of Sundog Ranch, Inc. The Reporting Person disclaims beneficial ownership of the securities held by Sundog Ranch, Inc. except to the extent of his pecuniary interest therein, if any.
F3 The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date.